• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM Back to Search Results
Catalog Number UNKNOWN RX ACCULINK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Transient Ischemic Attack (2109); Stenosis (2263); Obstruction/Occlusion (2422)
Event Date 06/01/2015
Event Type  Injury  
Manufacturer Narrative
Estimated date of event.Estimated date of implant.The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the part and lot number were not provided.The reported patient effects of stenosis, cerebrovascular accident and occlusion are listed in the rx acculink carotid stent system instructions for use as known patient effects associated with the use of a stent in carotid arteries.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.The accunet and viatrac devices referenced are being filed under separate medwatch mfr numbers.Attached article, titled "impact of cerebral blood perfusion and cognitive function of carotid artery stenting combined with medical therapy for patients with severe internal carotid stenosis."na.
 
Event Description
It was reported through a research article identifying that accunet embolic system, acculink stent and viatrac balloon may be related to the following: occlusion, restenosis, cerebral ischemic stroke, transient ischemic attack, medication, and rehospitalization.This article summarizes clinical outcomes of 62 patients that were treated with accunet, acculink stents and viatrac balloon.Details are listed in the attached article, titled "impact of cerebral blood perfusion and cognitive function of carotid artery stenting combined with medical therapy for patients with severe internal carotid stenosis.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX ACCULINK CAROTID STENT SYSTEM
Type of Device
CAROTID STENT
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12349839
MDR Text Key267535513
Report Number2024168-2021-07355
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P040012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN RX ACCULINK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/11/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ACCUNET EMBOLIC SYSTEM; VIATRAC BALLOON
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age65 YR
-
-